Skip to main content
SpringerLink
Log in

ASO Visual Abstract: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan

    Masaya Yamanaka MD, Masamichi Hayashi MD, PhD, Fuminori Sonohara MD, PhD, Suguru Yamada MD, PhD, Haruyoshi Tanaka MD, PhD, Daigo Kobayashi MD, Keisuke Kurimoto MD, PhD, Nobutake Tanaka MD, PhD, Yoshikuni Inokawa MD, PhD, Hideki Takami MD, PhD, Norifumi Hattori MD, PhD, Mitsuro Kanda MD, PhD, Chie Tanaka MD, PhD, Goro Nakayama MD, PhD, Masahiko Koike MD, PhD & Yasuhiro Kodera MD, PhD

  2. Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    Akihiro Sakai MD & Shinji Mii MD, PhD

Authors
  1. Masaya Yamanaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masamichi Hayashi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fuminori Sonohara MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Suguru Yamada MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Haruyoshi Tanaka MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Akihiro Sakai MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shinji Mii MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Daigo Kobayashi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Keisuke Kurimoto MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Nobutake Tanaka MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yoshikuni Inokawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Hideki Takami MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Norifumi Hattori MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Mitsuro Kanda MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Chie Tanaka MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Goro Nakayama MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Masahiko Koike MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Yasuhiro Kodera MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masamichi Hayashi MD, PhD.

Ethics declarations

Disclosure

We have nothing to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamanaka, M., Hayashi, M., Sonohara, F. et al. ASO Visual Abstract: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9. Ann Surg Oncol 29, 7192–7193 (2022). https://doi.org/10.1245/s10434-022-12084-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12084-0

Search

Navigation